Ovarian Dysgerminoma / Disgerminom Jajnika
References
- 1. Yoon S, Park HG, Kuk JY, Oak SA, Park JH. A case of ovarian dysgerminoma with gonadal dysgenesis in 29-year-old woman with 46,XX karyotype. Korean J Obstet Gynecol. 2012;55(10):772-6.
- 2. Smith HO, Berwick M, Verschraegen CF, Wiggins C, Lansing L, Muller CY, et al. Incidence and survival rates for female malignant germ cell tumors. Obstet Gynecol. 2006;107(5):1075-85.
- 3. Tangjitgamsol S, Hanprasertpong J, Manusirvithaya S, Wootipoom V, Thavaramara T, Buhachat R. Malignant ovarian germ cell tumors: clinic-pathological presentation and survival outcomes. ActaObstetGynecol Scand. 2010;89(2):182-9.
- 4. Vicus D, Beiner M, Klachook S, Le L, Laframboise S, Mackay H. Purge dysgerminoma of the ovary 35 years on: A single institutional experiences. GynecolOncol. 2010:117(1):23-6.
- 5. Biswajit D, Patil CN, Sagar TG. Clinical presentation and outcome of pediatric ovarian germ cell tumor: A study of 40 petients. J Pediatric Hematol Oncol.2010;32(2):e54-e56.
- 6. Boran N, Tulunay G, Callskan E, Kose MF, Haberal A. Pregnancy outcomes and menstrual function after fertility sparing surgery for pure ovarian dysgerminoma. Arch Gynecol Obstet. 2005;271:104-8.
- 7. Akhtar K, Shamshad Ahmad S, Kumar A, Afshan N. Dysgerminoma with pregnancy and viable baby: a case report. Oman Med J. 2011;26(3):198-200.
- 8. Kumar S, Shah JP, Bryant CS, Imudia AN, Cote ML, Ali- Fehmi R, et al. “The prevalence and prognostic impact of lymph node metastasis in malignant germ cell tumors of the ovary,” GynecolOncol. 2008; 110(2): 125-32.
- 9. Radhakrishhnan S, Haq S, Lofts F, Young MPA, Barton DRJ. Ovarian dysgerminoma presenting with hypercalcaemia. BJOG. 2001;108(12):1302-4.
- 10. Lee IH, Choi CH, Hong DG, Song JY, Kim YJ, Kim KT.et al. Clinicopathologic characteristics of granulosa cell tumors of the ovary: a multicenter retrospective study. J GynecolOncol. 2011;22:188-95.
- 11. Pautier P, Gutierrez-Bonnaire M, Rey A, Sillet-Bach I, Chevrean C, Kerbrat P, et al. Combination of bleomycin, etoposide, and cisplatin for the treatment of advanced ovarian granulosa cell tumors. Int J Gynecol Cancer. 2008;18:446-52.
- 12. Talukadar S, Kumar S, Bhatla N, Mathur S, Thulkar S, Kumar L. Neo-adjuvant chemotherapy in the treatment of advanced malignant germ cell tumors of ovary. Gynecol Oncol.2014;132:28.
- 13. Zanetta G, Bonazzi C, Cantu M, Binidagger S, Locatelli A, Bratina G, et al. Survival and reproductive function after treatment of malignant germ cell ovarian tumors. J ClinOncol. 2001;19(4):1015-20.
- 14. Colombo N, Peiretti M, Garbi A, Garinelli S, Marini C, Sessa C. Non-epithelial ovarian cancer: ESMO clinical practice guidelines. Ann Oncol. 2012;23(7):20-6.
DOI: https://doi.org/10.1515/sjecr-2015-0043 | Journal eISSN: 2956-2090 (formerly 2335-075X, 2956-0454) | Journal ISSN: 2956-0454 (formerly 1820-8665)
Language: English
Page range: 67 - 70
Submitted on: Feb 18, 2015
Accepted on: Mar 16, 2015
Published on: Apr 14, 2016
Published by: University of Kragujevac, Faculty of Medical Sciences
In partnership with: Paradigm Publishing Services
Related subjects:
© 2016 Ana Devic, Mladenko Vasiljevic, Aleksandar Devic, Marija Sorak, published by University of Kragujevac, Faculty of Medical Sciences
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.